Intravascular cell delivery device for therapeutic VEGF-induced angiogenesis in chronic vascular occlusion

Arun H.S. Kumar, Kenneth Martin, Brendan Doyle, Chien Ling Huang, Gopala Krishnan M. Pillai, Mohammed T. Ali, Kimberly A. Skelding, Shaohua Wang, Birgitta M. Gleeson, Saleem Jahangeer, Erik L. Ritman, Stephen J. Russell, Noel M. Caplice

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

Site specific targeting remains elusive for gene and stem cell therapies in the cardiovascular field. One promising option involves use of devices that deliver larger and more sustained cell/gene payloads to specific disease sites using the versatility of percutaneous vascular access technology. Smooth muscle cells (SMCs) engineered to deliver high local concentrations of an angiogenic molecule (VEGF) were placed in an intravascular cell delivery device (ICDD) in a porcine model of chronic total occlusion (CTO) involving ameroid placement on the proximal left circumflex (LC. x) artery. Implanted SMC were retained within the ICDD and were competent for VEGF production invitro and invivo. Following implantation, micro-CT analyses revealed that ICDD-VEGF significantly enhanced vasa vasora microvessel density with a concomitant increase in tissue VEGF protein levels and formation of endothelial cell colonies suggesting increased angiogenic potential. ICDD-VEGF markedly enhanced regional blood flow determined by microsphere and contrast CT analysis translating to a functional improvement in regional wall motion and global left ventricular (LV) systolic and diastolic function. Our data indicate robust, clinically relevant angiogenesis can be achieved in a human scale porcine chronic vascular occlusion model following ICDD-VEGF-based delivery of angiogenic cells. This may have implications for percutaneous delivery of numerous therapeutic factors promoting creation of microvascular bypass networks in chronic vaso-occlusive diseases.

Original languageEnglish (US)
Pages (from-to)9012-9022
Number of pages11
JournalBiomaterials
Volume35
Issue number32
DOIs
StatePublished - Oct 2014

Keywords

  • Angiogenesis
  • Blood flow
  • Gene therapy
  • Intravascular stent
  • Smooth muscle cells

ASJC Scopus subject areas

  • Bioengineering
  • Ceramics and Composites
  • Biophysics
  • Biomaterials
  • Mechanics of Materials

Fingerprint Dive into the research topics of 'Intravascular cell delivery device for therapeutic VEGF-induced angiogenesis in chronic vascular occlusion'. Together they form a unique fingerprint.

Cite this